Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trial.
- Colomer, R
- Llombart, A
- Lluch, A
- Ojeda, B
- Barnadas, A
- Caranana, V
- Fernandez, Y
- De Paz, L
- Guillem, V
- Alonso, S;
Seminars In Oncology (p. 20-24) - 4/3/2000
- ISSN 00937754
- iMarina
Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study
- Gascon, Pere
- Rodriguez, Cesar A
- Valentin, Vicente
- Mata, Jesus Garcia
- Carulla, Joan
- Cassinello, Javier
- Colomer, Ramon
- Baro, Eva
Supportive Care In Cancer (p. 3039-3049) - 1/11/2013
10.1007/s00520-013-1862-z Ver en origen
- ISSN 09414355
Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer
- Baro, Eva
- Carulla, Joan
- Cassinello, Javier
- Colomer, Ramon
- Garcia Mata, Jesus
- Gascon, Pere
- Antonio Gasquet, Jose
- Rodriguez, Cesar A
- Valentin, Vicente
Supportive Care In Cancer (p. 657-666) - 1/5/2011
10.1007/s00520-010-0878-x Ver en origen
- ISSN 09414355
P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with …
- J Albanell
- R Colomer
- M Ruiz-Borrego
- E Alba
- JA García Saenz
- M Martin
- I Tusquets
- F Rojo
- I Faull
- A Lluch
The Breast (p. S43-S43) - 1/1/2011
- iMarina
Prognostic value of cytosolic p53 protein in breast cancer
- Montero, S
- Guzman, C
- Vargas, C
- Ballestin, C
- Cortes-Funes, H
- Colomer, R;
Tumor Biology (p. 337-344) - 1/1/2001
10.1159/000050636 Ver en origen
- ISSN 10104283
Development of a New Questionnaire to Assess Patient Perceptions of Cancer-Related Fatigue: Item Generation and Item Reduction
- Baro, Eva
- Carulla, Joan
- Cassinello, Javier
- Colomer, Ramon
- Mata, Jesus Garcia
- Gascon, Pere
- Gasquet, Jose Antonio
- Herdman, Michael
- Rodriguez, Cesar A
- Sanchez, Jordi
- Valentin, Vicente
Value In Health (p. 130-138) - 1/1/2009
10.1111/j.1524-4733.2008.00426.x Ver en origen
- ISSN 10983015
Gemcitabine in combination with paclitaxel for the treatment of metastatic breast cancer
- Ramon Colomer
Women's Health (London, England) (p. 323-329) - 1/11/2005
10.2217/17455057.1.3.323 Ver en origen
- ISSN 17455065
- iMarina
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Tratado de oncología
- Hernán Cortés-Funes
- Ramón Colomer Bosch
- Emilio Alba Conejo
1/1/2009
- ISBN 9788492620166
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Medicina de precisión en oncología: Éxitos y perspectivas bioéticas
- Ramón Colomer Bosch
Bioética Y Cáncer (p. 17-26) - 1/1/2020
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Her-2/neu-induced cytokine signature in breast cancer
- Alejandro Vazquez-Martin
- Ramon Colomer
- Javier A Menendez
Advances In Experimental Medicine And Biology (p. 311-319) - 1/12/2008
10.1007/978-0-387-69080-3_29 Ver en origen
- ISSN 00652598
- iMarina
- iMarina
Gemcitabine- and taxane-based protocols in breast cancer [Protocoles à base de gemcitabine et taxanes dans le cancer du sein]
- Colomer R
American Journal Of Cancer (p. 19-20) - 1/11/2004
10.2165/00024669-200403992-00009 Ver en origen
- ISSN 11756357
PROSPECTIVE TRANSGEICAM STUDY OF ONCOTYPE DX (R) IN CLINICAL DECISION MAKING IN ESTROGEN RECEPTOR-POSITIVE NODE-NEGATIVE BREAST CANCER WOMEN
- Albanell, J.
- Colomer, R.
- Ruiz-Borrego, M.
- Saenz, J. A. Garcia
- Alba, E.
- Martin, M.
- Palacios, J.
- Faull, I.
- Corominas, J. M.
- Lluch, A.;
Annals Of Oncology (p. 81-81) - 1/1/2010
- ISSN 09237534
- iMarina
Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy
- Rogado, J.
- Pozo, F.
- Troule, K.
- Sanchez-Torres, J. M.
- Romero Laorden, N.
- Mondejar Solis, R.
- Donnay Candil, O.
- Ballesteros Garcia, A. I.
- Pacheco-Barcia, V.
- Aspa, J.
- Al-Shahrour, F.
- Alfranca, A.
- Colomer, R.;
Annals Of Oncology (p. S999-S1000) - 1/1/2021
10.1016/j.annonc.2021.08.1889 Ver en origen
- ISSN 09237534
Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial
- Dang, C.
- Ewer, M. S.
- Delaloge, S.
- Ferrero, J-M.
- Colomer, R.
- de la Cruz Merino, L.
- Dadswell, K.
- Verrill, M.
- Eiger, D.
- Sarkar, S.
- de Haas, S.
- Restuccia, E.
- Swain, S. M.;
Annals Of Oncology (p. S38-S39) - 1/5/2021
10.1016/j.annonc.2021.03.057 Ver en origen
- ISSN 09237534
Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival
- V Pacheco-Barcia
- T France
- G Zogopoulos
- N Bouganim
- O Donnay
- T Alcindor
- R Mondéjar Solís
- K Guo
- E Martin
- R Colomer
- J Asselah
Annals Of Oncology (p. mdy151. 163-mdy151. 163) - 1/1/2018
- ISSN 09237534
- iMarina
Safety of self-expandable metal stents (SEMS) or emergency surgery for acute colonic obstruction in metastatic colon cancer patients treated with bevacizumab
- Pacheco-Barcia, V.
- Mondejar Solis, R.
- Martinez Saez, O.
- Longo Munoz, F.
- Bermejo, E.
- Moreno Monteagudo, J.
- Marin, C.
- Correa, A.
- Maqueda, R.
- Rogado, J.
- Garcia de Paredes, A.
- Rodriguez de Santiago, E.
- Pachon Olmos, V.
- Ferreiro Monteagudo, R.
- Rodriguez Garrote, M.
- Carrato, A.
- Donnay, O.
- Martin, E.
- Santander, C.
- Colomer, R.;
Annals Of Oncology - 1/1/2018
- ISSN 09237534
- iMarina
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study
- Im, S-A.
- Tan, A. R.
- Mattar, A.
- Colomer, R.
- Stroyakovskii, D.
- Nowecki, Z.
- De Laurentiis, M.
- Pierga, J-Y.
- Jung, K. H.
- Schem, C.
- Aguila, C.
- Crnjevic, T. Badovinac
- Heeson, S.
- Shivhare, M.
- Alexandrou, A.
- Restuccia, E.
- Jackisch, C.;
Annals Of Oncology (p. S40-S41) - 1/5/2021
10.1016/j.annonc.2021.03.060 Ver en origen
- ISSN 09237534
The impact of primary tumor location in patients with resected colorectal liver metastasis
- Pacheco-Barcia, V.
- Donnay, O.
- Solis, R. Mondejar
- Serrano, R.
- Martin, E.
- del Campo, L.
- Rogado, J.
- Vera, B.
- Ballesteros, A.
- Colomer, R.;
Annals Of Oncology - 1/1/2018
- ISSN 09237534
- iMarina
Could a systemic inflammation response index (SIRI) predict overall survival (OS) in metastatic pancreatic cancer (PC)?
- Pacheco-Barcia, V.
- Donnay, O.
- Mondejar, R.
- Rogado, J.
- Fenor de la Maza, M. D.
- Colomer, R.;
Annals Of Oncology - 1/1/2017
- ISSN 09237534
- iMarina
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas
- Rebeca Mondéjar Solís (Director)
- Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia
28/1/2021
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id